$4.850
-0.164 (-3.39%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ORMP Prediction & Forecast by Similar Chart Analysis
Alphio's ORMP stock price prediction model matches the current Oramed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.83 (-0.35%). The 1-week path is $4.76 (-1.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Oramed Pharmaceuticals Inc Stock?
Oramed Pharmaceuticals is a good buy right now due to its recent strong performance, including a 72.85% year-to-date change and a significant profit of $10 million in Q4 2026, which indicates growing profitability despite low revenue. The RSI is at 60.85, suggesting the stock is gaining momentum. However, the main risk is the high volatility indicated by an implied volatility of 300.1, which could lead to unpredictable price movements.
ORMP stock price ended at $4.85 on Tuesday, after losing -3.39%
Oramed Pharmaceuticals Inc (ORMP) last closed at $4.85, losing -3.39%. These facts feed the 1-day and 1-week ORMP price prediction above.
Analyst Consensus
Oramed Pharmaceuticals Inc (ORMP): 2 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Oramed Pharmaceuticals Inc (ORMP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ORMP, ranked by similarity.
Seasonality analysis for ORMP
Historically the probability of a positive September return for ORMP is 28.57%. December offers the highest probability of a positive month at 74.42%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ORMP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $1.65 | $2.07 | $2.29 | -57.33% |
| Oct 2026 | $2.53 | $2.56 | $2.64 | -47.22% |
| Nov 2026 | $1.92 | $2.16 | $2.28 | -55.40% |
| Dec 2026 | $2.47 | $2.51 | $2.54 | -48.29% |
In 2026, Oramed Pharmaceuticals Inc (ORMP) is projected to range from $1.65 to $2.64.
Oramed Pharmaceuticals Inc 2026 monthly forecast
In Sep 2026, Oramed Pharmaceuticals Inc is projected to average $2.07, with a low of $1.65 and high of $2.29.
In Oct 2026, Oramed Pharmaceuticals Inc is projected to average $2.56, with a low of $2.53 and high of $2.64.
In Nov 2026, Oramed Pharmaceuticals Inc is projected to average $2.16, with a low of $1.92 and high of $2.28.
In Dec 2026, Oramed Pharmaceuticals Inc is projected to average $2.51, with a low of $2.47 and high of $2.54.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.